http://dbpedia.org/ontology/abstract
|
The Recombinant Immunotoxin Collaborative … The Recombinant Immunotoxin Collaborative Group (RICG) is a group of scientists specialising in immunology, biochemistry and molecular biology from the United Kingdom and Italy. The group is working toward the development of genetically engineered immunotoxins made from monoclonal antibody fragments genetically fused to either saporin or Pseudomonas exotoxin (PE) for the treatment of human hematological malignancies such as leukaemia, lymphoma and multiple myeloma. leukaemia, lymphoma and multiple myeloma.
|
http://dbpedia.org/ontology/wikiPageID
|
30637345
|
http://dbpedia.org/ontology/wikiPageLength
|
2879
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1077884050
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/University_of_Verona +
, http://dbpedia.org/resource/Saporin +
, http://dbpedia.org/resource/Hematological_malignancies +
, http://dbpedia.org/resource/University_of_Southampton +
, http://dbpedia.org/resource/Lymphoma +
, http://dbpedia.org/resource/CD38 +
, http://dbpedia.org/resource/CD22 +
, http://dbpedia.org/resource/Multiple_myeloma +
, http://dbpedia.org/resource/University_of_L%27Aquila +
, http://dbpedia.org/resource/Leukaemia_Busters +
, http://dbpedia.org/resource/Pseudomonas_exotoxin +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Category:Immunology_organizations +
, http://dbpedia.org/resource/University_of_Siena +
, http://dbpedia.org/resource/Leukaemia +
, http://dbpedia.org/resource/David_Flavell +
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cn +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Immunology_organizations +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Group +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Recombinant_Immunotoxin_Collaborative_Group?oldid=1077884050&ns=0 +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Recombinant_Immunotoxin_Collaborative_Group +
|
owl:sameAs |
http://rdf.freebase.com/ns/m.0g9wvv8 +
, http://www.wikidata.org/entity/Q7302703 +
, https://global.dbpedia.org/id/4u9jW +
, http://dbpedia.org/resource/Recombinant_Immunotoxin_Collaborative_Group +
, http://yago-knowledge.org/resource/Recombinant_Immunotoxin_Collaborative_Group +
|
rdf:type |
http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/WikicatImmunologyOrganizations +
, http://dbpedia.org/ontology/Band +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Group100031264 +
|
rdfs:comment |
The Recombinant Immunotoxin Collaborative … The Recombinant Immunotoxin Collaborative Group (RICG) is a group of scientists specialising in immunology, biochemistry and molecular biology from the United Kingdom and Italy. The group is working toward the development of genetically engineered immunotoxins made from monoclonal antibody fragments genetically fused to either saporin or Pseudomonas exotoxin (PE) for the treatment of human hematological malignancies such as leukaemia, lymphoma and multiple myeloma. leukaemia, lymphoma and multiple myeloma.
|
rdfs:label |
Recombinant Immunotoxin Collaborative Group
|